164 related articles for article (PubMed ID: 29940588)
1. Scotopic Microperimetric Assessment of Rod Function in Stargardt Disease (SMART) Study: Design and Baseline Characteristics (Report No. 1).
Strauss RW; Kong X; Bittencourt MG; Ho A; Jha A; Schönbach EM; Ahmed MI; Muñoz B; Ervin AM; Michaelides M; Birch DG; Sahel JA; Sunness JS; Zrenner E; Bagheri S; Ip M; Sadda S; West S; Scholl HPN;
Ophthalmic Res; 2019; 61(1):36-43. PubMed ID: 29940588
[TBL] [Abstract][Full Text] [Related]
2. Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7.
Schönbach EM; Wolfson Y; Strauss RW; Ibrahim MA; Kong X; Muñoz B; Birch DG; Cideciyan AV; Hahn GA; Nittala M; Sunness JS; Sadda SR; West SK; Scholl HPN;
JAMA Ophthalmol; 2017 Jul; 135(7):696-703. PubMed ID: 28542693
[TBL] [Abstract][Full Text] [Related]
3. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.
Strauss RW; Ho A; Muñoz B; Cideciyan AV; Sahel JA; Sunness JS; Birch DG; Bernstein PS; Michaelides M; Traboulsi EI; Zrenner E; Sadda S; Ervin AM; West S; Scholl HP;
Ophthalmology; 2016 Apr; 123(4):817-28. PubMed ID: 26786511
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Microperimetric Changes of Macular Sensitivity in Stargardt Disease After 12 Months: ProgStar Report No. 13.
Schönbach EM; Strauss RW; Muñoz B; Wolfson Y; Ibrahim MA; Birch DG; Zrenner E; Sunness JS; Ip MS; Sadda SR; West SK; Scholl HPN;
JAMA Ophthalmol; 2020 Jul; 138(7):772-779. PubMed ID: 32463436
[TBL] [Abstract][Full Text] [Related]
5. The Progression of the Stargardt Disease Type 4 (ProgStar-4) Study: Design and Baseline Characteristics (ProgStar-4 Report No. 1).
Strauss RW; Muñoz B; Ahmed MI; Bittencourt M; Schönbach EM; Michaelides M; Birch D; Zrenner E; Ervin AM; Charbel Issa P; Kong J; Wolfson Y; Shah M; Bagheri S; West S; Scholl HPN;
Ophthalmic Res; 2018; 60(3):185-194. PubMed ID: 30110705
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Changes in Scotopic and Mesopic Macular Function as Assessed with Microperimetry in Patients With Stargardt Disease: SMART Study Report No. 2.
Kong X; Ibrahim-Ahmed M; Bittencourt MG; Strauss RW; Birch DG; Cideciyan AV; Ervin AM; Ho A; Sunness JS; Audo IS; Michaelides M; Zrenner E; Sadda S; Ip MS; West S; Scholl HPN;
Am J Ophthalmol; 2022 Apr; 236():32-44. PubMed ID: 34695402
[TBL] [Abstract][Full Text] [Related]
7. Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9).
Strauss RW; Muñoz B; Ho A; Jha A; Michaelides M; Cideciyan AV; Audo I; Birch DG; Hariri AH; Nittala MG; Sadda S; West S; Scholl HPN;
JAMA Ophthalmol; 2017 Nov; 135(11):1232-1241. PubMed ID: 29049437
[TBL] [Abstract][Full Text] [Related]
8. Retinal Sensitivity Using Microperimetry in Age-Related Macular Degeneration in an Amish Population.
Nittala MG; Velaga SB; Hariri A; Pfau M; Birch DG; Haines J; Pericak-Vance MA; Stambolian D; Sadda SR
Ophthalmic Surg Lasers Imaging Retina; 2019 Sep; 50(9):e236-e241. PubMed ID: 31589764
[TBL] [Abstract][Full Text] [Related]
9. Morpho-functional correlation of fundus autofluorescence in Stargardt disease.
Parodi MB; Iacono P; Triolo G; La Spina C; Zucchiatti I; Cicinelli MV; Borrelli E; Manitto MP; Martina E; Bandello F
Br J Ophthalmol; 2015 Oct; 99(10):1354-9. PubMed ID: 25837607
[TBL] [Abstract][Full Text] [Related]
10. Visual Acuity Change Over 24 Months and Its Association With Foveal Phenotype and Genotype in Individuals With Stargardt Disease: ProgStar Study Report No. 10.
Kong X; Fujinami K; Strauss RW; Munoz B; West SK; Cideciyan AV; Michaelides M; Ahmed M; Ervin AM; Schönbach E; Cheetham JK; Scholl HPN;
JAMA Ophthalmol; 2018 Aug; 136(8):920-928. PubMed ID: 29902293
[TBL] [Abstract][Full Text] [Related]
11. Incidence of Atrophic Lesions in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 5.
Strauss RW; Muñoz B; Ho A; Jha A; Michaelides M; Mohand-Said S; Cideciyan AV; Birch D; Hariri AH; Nittala MG; Sadda S; Scholl HPN;
JAMA Ophthalmol; 2017 Jul; 135(7):687-695. PubMed ID: 28542697
[TBL] [Abstract][Full Text] [Related]
12. Multimodal analysis of the Preferred Retinal Location and the Transition Zone in patients with Stargardt Disease.
Verdina T; Greenstein VC; Sodi A; Tsang SH; Burke TR; Passerini I; Allikmets R; Virgili G; Cavallini GM; Rizzo S
Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1307-1317. PubMed ID: 28365912
[TBL] [Abstract][Full Text] [Related]
13. Correlation between photoreceptor layer integrity and visual function in patients with Stargardt disease: implications for gene therapy.
Testa F; Rossi S; Sodi A; Passerini I; Di Iorio V; Della Corte M; Banfi S; Surace EM; Menchini U; Auricchio A; Simonelli F
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4409-15. PubMed ID: 22661472
[TBL] [Abstract][Full Text] [Related]
14. Spatial Dissociation of Subretinal Drusenoid Deposits and Impaired Scotopic and Mesopic Sensitivity in AMD.
Zhang Y; Sadda SR; Sarraf D; Swain TA; Clark ME; Sloan KR; Warriner WE; Owsley C; Curcio CA
Invest Ophthalmol Vis Sci; 2022 Feb; 63(2):32. PubMed ID: 35212721
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal Analysis of Structural and Functional Changes in Presence of Reticular Pseudodrusen Associated With Age-Related Macular Degeneration.
Sassmannshausen M; Pfau M; Thiele S; Fimmers R; Steinberg JS; Fleckenstein M; Holz FG; Schmitz-Valckenberg S
Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):19. PubMed ID: 32780863
[TBL] [Abstract][Full Text] [Related]
16. The Progression of Stargardt Disease Using Volumetric Hill of Vision Analyses Over 24 Months: ProgStar Report No.15.
Schönbach EM; Janeschitz-Kriegl L; Strauss RW; Cattaneo MEGV; Fujinami K; Birch DG; Cideciyan AV; Sunness JS; Weleber RG; Ip MS; Sadda SR; Scholl HPN;
Am J Ophthalmol; 2021 Oct; 230():123-133. PubMed ID: 33951446
[TBL] [Abstract][Full Text] [Related]
17. SCOTOPIC AND FAST MESOPIC MICROPERIMETRY IN EYES WITH DRUSEN AND RETICULAR PSEUDODRUSEN.
Corvi F; Pellegrini M; Belotti M; Bianchi C; Staurenghi G
Retina; 2019 Dec; 39(12):2378-2383. PubMed ID: 30180145
[TBL] [Abstract][Full Text] [Related]
18. Macular function and morphologic features in juvenile stargardt disease: longitudinal study.
Testa F; Melillo P; Di Iorio V; Orrico A; Attanasio M; Rossi S; Simonelli F
Ophthalmology; 2014 Dec; 121(12):2399-405. PubMed ID: 25097154
[TBL] [Abstract][Full Text] [Related]
19. Visual Acuity Change over 12 Months in the Prospective Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: ProgStar Report Number 6.
Kong X; Strauss RW; Cideciyan AV; Michaelides M; Sahel JA; Munoz B; Ahmed M; Ervin AM; West SK; Cheetham JK; Scholl HPN;
Ophthalmology; 2017 Nov; 124(11):1640-1651. PubMed ID: 28549516
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal Changes of Fixation Location and Stability Within 12 Months in Stargardt Disease: ProgStar Report No. 12.
Schönbach EM; Strauss RW; Kong X; Muñoz B; Ibrahim MA; Sunness JS; Birch DG; Hahn GA; Nasser F; Zrenner E; Sadda SR; West SK; Scholl HPN;
Am J Ophthalmol; 2018 Sep; 193():54-61. PubMed ID: 29890160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
